Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q1

3353.TEDINET S100OPR7
Period2022-03-01 → 2022-05-31
Filed2022-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.6bn2022-03-01 → 2022-05-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥8.5bn2021-03-01 → 2021-05-31Cons.Net sales
Operating income¥239m2022-03-01 → 2022-05-31Cons.Operating income
Operating income¥303m2021-03-01 → 2021-05-31Cons.Operating income
Ordinary income¥313m2022-03-01 → 2022-05-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥316m2021-03-01 → 2021-05-31Cons.Ordinary income
Profit before tax¥334m2022-03-01 → 2022-05-31Cons.Income before income taxes
Profit before tax¥386m2021-03-01 → 2021-05-31Cons.Income before income taxes
Net income (owners)¥208m2022-03-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥226m2021-03-01 → 2021-05-31Cons.Profit loss attributable to owners of parent
Net income¥213m2022-03-01 → 2022-05-31Cons.Profit loss
Net income¥226m2021-03-01 → 2021-05-31Cons.Profit loss
Total assets¥28.8bnat 2022-05-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥28.3bnat 2021-05-31Cons.Total assets (5-year summary)
Total liabilities¥16.8bnat 2022-05-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥10.6bnat 2021-05-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2022-05-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
EPS (basic)¥55.392022-03-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.092021-03-01 → 2021-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio39.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio37.5%at 2021-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-05-31−¥253m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-05-31−¥189m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-05-31¥5.9bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-05-31¥363m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-05-31¥1.9bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-05-31¥19m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-05-31¥946m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-05-31¥694m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥252m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-05-31¥16m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-05-31¥49m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-05-31¥381,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-05-31¥30m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-05-31¥8.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-05-31¥253m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-05-31¥428m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-05-31−¥278m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-05-31−¥180m
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-05-31¥5.8bn
jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-05-31¥340m
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-05-31¥2.0bn
jpcrp040300-q1r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥150,000
jpcrp040300-q1r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-05-31¥74m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-05-31¥1.0bn
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-05-31¥726m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥278m
jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-05-31¥36m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-05-31¥59m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-05-31¥58m
jpcrp040300-q1r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-05-31¥540,000
jpcrp040300-q1r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-05-31¥33m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-05-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-05-31¥8.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-05-31¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-05-31¥483m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 353
ItemContextValueUnit
Operating incomePrior1YTDDuration302515000JPY
Operating incomeCurrentYTDDuration239051000JPY
Interest income noiPrior1YTDDuration355000JPY
Interest income noiCurrentYTDDuration309000JPY
Dividends income noiPrior1YTDDuration466000JPY
Dividends income noiCurrentYTDDuration442000JPY
Subsidy income noi bountyPrior1YTDDuration18519000JPY
Subsidy income noi bountyCurrentYTDDuration31642000JPY
Gain on reversal of advance received noiPrior1YTDDuration－JPY
Gain on reversal of advance received noiCurrentYTDDuration48528000JPY
Other noiPrior1YTDDuration9924000JPY
Other noiCurrentYTDDuration6458000JPY
Non operating incomePrior1YTDDuration29266000JPY
Non operating incomeCurrentYTDDuration87381000JPY
Interest expenses noePrior1YTDDuration14662000JPY
Interest expenses noeCurrentYTDDuration13659000JPY
Other noePrior1YTDDuration878000JPY
Other noeCurrentYTDDuration123000JPY
Non operating expensesPrior1YTDDuration15540000JPY
Non operating expensesCurrentYTDDuration13783000JPY
Ordinary incomePrior1YTDDuration316241000JPY
Ordinary incomeCurrentYTDDuration312649000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration9000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration20497000JPY
Gain on sales of investment securities eiPrior1YTDDuration74885000JPY
Gain on sales of investment securities eiCurrentYTDDuration429000JPY
Extraordinary incomePrior1YTDDuration74895000JPY
Extraordinary incomeCurrentYTDDuration20926000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration590000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration0JPY
Loss on cancellation of leasehold contracts elPrior1YTDDuration4352000JPY
Loss on cancellation of leasehold contracts elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration4942000JPY
Extraordinary lossCurrentYTDDuration0JPY
Income before income taxesPrior1YTDDuration386193000JPY
Income before income taxesCurrentYTDDuration333576000JPY
Income taxes currentPrior1YTDDuration215050000JPY
Income taxes currentCurrentYTDDuration145537000JPY
Income taxes deferredPrior1YTDDuration-54567000JPY
Income taxes deferredCurrentYTDDuration-25048000JPY
Income taxesPrior1YTDDuration160482000JPY
Income taxesCurrentYTDDuration120489000JPY
Profit lossPrior1YTDDuration225711000JPY
Profit lossCurrentYTDDuration213087000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration5023000JPY
Profit loss attributable to owners of parentPrior1YTDDuration225711000JPY
Profit loss attributable to owners of parentCurrentYTDDuration208063000JPY
Profit lossPrior1YTDDuration225711000JPY
Profit lossCurrentYTDDuration213087000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-05-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-05-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass